Science Market Update

$8M Research Grant Awarded to UAB, Duke, & UW Collaborative Study

Posted by Emily Olson on Wed, Sep 28, 2016

The $8M grant, given by the National Heart, Lung, and Blood Institute, will support a project in which the research team will use bioengineered stem cells and tissue to create a functional heart patch. The patch will restore function and prevent heart failure that can be caused by a heart attack's damage.
Read More

Tags: Stem Cells, heart disease, Duke University, University of Wisconsin Madison, Alabama, UAB, AL, Southern Region, University of Alabama at Birmingham, bioengineering

$29M Core Grant Awarded to Alabama for Cancer Research Center

Posted by Rebecca Partridge on Wed, Jun 29, 2016

(Image courtesy of Wikimedia commons)

University of Alabama at Birmingham received a $29 million grant from the National Cancer Institute. This five year core grant will support six research programs at the UAB Comprehensive Cancer Center. The renewal of the Cancer Center Support Grant, the most prestigious federal grant that a cancer research and treatment program can earn, also extends UAB’s elite “comprehensive” designation. According to the UAB News website this designation is awarded for scientific excellence and the ability to integrate diverse research approaches in the fight against cancer.

Read More

Tags: Bioresearch funding, cancer research, Alabama, University of Alabama, Cancer Treatment, Cancer, University of Alabama Birmingham, UAlab, UAB, University of Alabama at Birmingham, Cancer Center, cancer researchers, fight cancer, 2016, cancer reserach, Bioresearch Grant, Comprehensive Cancer Center

Research at UAB Leads to Potential New Treatment for Parkinson’s

Posted by Rebecca Partridge on Mon, Jun 06, 2016

(1886 Sketch of Person with Parkinson's by Sir William Richard Gowers Courtesy of Wikimedia Commons)

Researchers at the University of Alabama, Birmingham have discovered a potential new approach to reducing the damage done by Parkinson's disease. They found that suppressing a key cell-signaling pathway in the brain lessened the destructive inflammation and nerve degradation in the area of the brain affected by Parkinson’s. In the study, rats were used to model the disease by inducing an overexpression of a-synuclein, a protein that is abundant in the human brain. The accumulation of α-synuclein is a core feature of Parkinson’s disease. This accumulation leads to the activation of the brain's immune cells and the production of inflammatory signaling chemicals, which leads to neurodegradation. The rats that were then given a JAK/STAT pathway inhibitors (known as Jakinibs) did not have the immune response, the inflammatory activation, or the neurodegeneration that those that did not receive the inhibitor experienced.    

Read More

Tags: Parkinson's Disease Research, Alabama, University of Alabama, University of Alabama Birmingham, UAlab, Birmingham, AL, University of Alabama at Birmingham, 2016, Parkinson's Disease

UAB Scientists Uncover TNT in Fight Against TB

Posted by Robert Larkin on Mon, Oct 12, 2015

Tuberculosis is a terrible disease that is characterized by a bad, sometimes bloody cough, and which could lead to other serious health problems, or even death.

Over 1.5 million people currently die from TB each year, and as many as one third of the world’s population is currently infected, according to the Centers for Disease Control and Prevention.

In an effort to combat this worldwide health concern, Michael Niederweis, Ph.D., and colleagues from the University of Alabama at Birmingham have made an important discovery. The scientists recently uncovered an important toxin called Tuberculosis Necrotizing Toxin (TNT) that resides within the pathogenic bacterium Mycobacterium tuberculosis and aids in survival and proliferation.

Read More

Tags: tuberculosis, Immunology, Alabama, Biology, 2015, disease research, life science research, UAlab, Birmingham, AL, Southern Region, University of Alabama at Birmingham, BioResearch Product Faire™

U. Alabama Analytical Lab Study Shows Lipid Count Impacts Parkinson’s

Posted by Jennifer Nieuwkerk on Fri, Sep 19, 2014

With fundraising campaigns such as the ALS ice bucket challenge in the news, diseases of the nervous system have recently received a great deal of attention from both the media and life science researchers. Parkinson’s disease in particular has been the subject of a recent study at the University of Alabama. Scientists at the university discovered that the deficiency of a type of lipid that naturally declines as the brain ages leads to increases in a protein associated with Parkinson’s disease.

 “This gets right to the heart of understanding, possibly, the mechanism by which one form of lipid is impacting the process of neuron degeneration,” said Dr. Guy Caldwell, UA professor of biological sciences and one of the study’s co-authors.

Read More

Tags: 2014, Alabama

Life Science Grant Worth $8.1M Awarded to University of Alabama

Posted by Jennifer Nieuwkerk on Fri, Jul 18, 2014

Researchers at the University of Alabama recently received $8.1 million in life science funding from the National Institutes of Health for a study involving the etiology of geographic and racial differences in stroke. The life science grant was awarded in January of 2014 by the National Institute of Neurological Disorders and Stroke, a branch within the National Institutes of Health.

Read More

Tags: 2014, new research funding, Alabama, University of Alabama, University of Alabama Birmingham, BioResearch Product Faire Event, UAlab, Birmingham, AL, new grant

Life Science Market News Helps with Marketing and Sales

Posted by yolanda lerner on Mon, Sep 16, 2013

Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.

Read More

Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB

UAB Study Shows Ferritin Prevents Iron-Related Kidney Damage

Posted by Morgan Imel on Thu, Sep 12, 2013

Iron is the most common chemical element found on earth, and it plays a key role in the biochemical processes of almost all organisms. Though iron is an important building block of life, it is also attributed to causing cellular damage when it is released into its free catalytic form. Researchers at the University of Alabama at Birmingham recently published a report in the Journal of Clinical Investigation which sought to help understand the relationship between the protein ferritin and kidney damage caused by this free iron. This study set a foundation for future research into potential treatments to prevent acute kidney injury.

Read More

Tags: 2014, 2013, Alabama, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, University of Alabama at Birmingham

U. Alabama Receives $2.2M for Pancreatic Cancer Research

Posted by Jennifer Nieuwkerk on Wed, Sep 04, 2013

Researchers at the University of Alabama at Birmingham, led by Donald Buchsbaum, PhD, received a $2.2 million grant from the NIH this year to study pancreatic cancer. According to the University of Alabama website, Dr. Buchsbaum is quoted as saying of his research goals: "My interests are focused on the use of monoclonal antibodies that bind to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors for cancer therapy in combination with chemotherapy agents and radiation.” Dr. Buchsbaum and his research team began receiving funding for their studies of pancreatic cancer six years ago, though funding was limited at that time. The NIH RePORTER sheds light on the project that has received $2.2 million from the NIH this year in the proposal’s abstract:

Read More

Tags: 2014, 2013, Alabama, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, AL, NIH funding, NIH grant, NIH award, University of Alabama at Birmingham

University of Alabama Receives $5.1M NIH Grant

Posted by Jennifer Nieuwkerk on Wed, Aug 21, 2013

Researchers at the University of Alabama, Birmingham Comprehensive Cancer Center received a $5.1 million support grant from the NIH this year. The abstract for the grant on NIH RePORTER says of the Comprehensive Cancer Center:

Read More

Tags: 2014, 2013, Alabama, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, AL, NIH funding, NIH grant, NIH award, University of Alabama at Birmingham

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News